Long-term follow-up of five yr shows superior renal function with everolimus plus early calcineurin inhibitor withdrawal in the PROTECT randomized liver transplantation study.
Sterneck M, Kaiser GM, Heyne N, Richter N, Rauchfuss F, Pascher A, Schemmer P, Fischer L, Klein CG, Nadalin S, Lehner F, Settmacher U, Gotthardt D, Loss M, Ladenburger S, Wimmer P, Dworak M, Schlitt HJ.
Sterneck M, et al. Among authors: settmacher u.
Clin Transplant. 2016 Jun;30(6):741-8. doi: 10.1111/ctr.12744. Epub 2016 May 10.
Clin Transplant. 2016.
PMID: 27160359
Clinical Trial.